Free Trial
→ You cannot escape this reality (From Porter & Company) (Ad)tc pixel Free CLBT Stock Alerts

Cellebrite DI (CLBT) Financials

Cellebrite DI logo
$12.89 -0.29 (-2.20%)
As of 04:00 PM Eastern
Compare
Annual Income Statements for Cellebrite DI

Annual Income Statements for Cellebrite DI

This table shows Cellebrite DI's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -1.88 5.78 71 121 -81 -283 78
Consolidated Net Income / (Loss)		 -1.88 5.78 71 121 -81 -283 78
Net Income / (Loss) Continuing Operations		 -1.88 5.78 71 121 -81 -283 78
Total Pre-Tax Income 		1.42 11 82 121 -76 -276 91
Total Operating Income		 -1.52 9.22 14 1.04 33 57 66
Total Gross Profit		 136 157 204 220 272 339 401
Total Revenue		 172 195 246 271 325 401 476
Operating Revenue		 172 195 246 271 325 401 476
Total Cost of Revenue		 36 38 43 51 53 63 75
Operating Cost of Revenue		 36 38 43 51 53 63 75
Total Operating Expenses		 138 148 190 219 239 282 334
Selling, General & Admin Expense		 29 32 48 41 43 51 65
Marketing Expense		 62 61 76 97 111 132 155
Research & Development Expense		 47 54 66 81 84 98 114
Total Other Income / (Expense), net		 2.94 2.18 68 120 -109 -333 24
Other Income / (Expense), net		 2.94 2.18 68 120 -109 -333 24
Income Tax Expense		 3.29 5.62 11 -0.05 5.54 7.02 12
Basic Earnings per Share		 ($0.08) ($0.08) $0.49 $0.64 ($0.43) ($1.35) $0.32
Weighted Average Basic Shares Outstanding		 121.56M 123.70M 144.00M 182.69M 190.15M 209.47M 241.63M
Diluted Earnings per Share		 ($0.08) ($0.08) $0.44 $0.59 ($0.43) ($1.35) $0.31
Weighted Average Diluted Shares Outstanding		 121.56M 123.70M 161.54M 195.39M 190.15M 209.47M 249.90M
Weighted Average Basic & Diluted Shares Outstanding		 - - 188.54M 205.30M - 239.47M 249.44M

Quarterly Income Statements for Cellebrite DI

No quarterly income statements for Cellebrite DI are available.

Annual Cash Flow Statements for Cellebrite DI

This table details how cash moves in and out of Cellebrite DI's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 45 51 13 -57 101 3.35 -70
Net Cash From Operating Activities		 16 67 36 21 102 132 174
Net Cash From Continuing Operating Activities		 16 67 36 21 102 132 174
Net Income / (Loss) Continuing Operations		 -1.88 5.78 71 121 -81 -283 78
Consolidated Net Income / (Loss)		 -1.88 5.78 71 121 -81 -283 78
Depreciation Expense		 4.08 5.88 7.01 9.19 10 11 12
Amortization Expense		 - 0.00 0.00 -0.37 -1.11 -2.90 -2.37
Non-Cash Adjustments To Reconcile Net Income		 13 7.96 -61 -105 131 370 44
Changes in Operating Assets and Liabilities, net		 1.17 47 19 -3.92 43 38 42
Net Cash From Investing Activities		 -47 -6.45 45 -91 -23 -149 -268
Net Cash From Continuing Investing Activities		 -47 -6.45 45 -91 -23 -149 -268
Purchase of Property, Plant & Equipment		 -6.21 -6.18 -5.11 -6.90 -5.23 -8.57 -13
Acquisitions		 0.00 -15 -23 -2.19 -2.69 -4.79 -147
Purchase of Investments		 -41 -139 -21 -165 -144 -335 -508
Sale and/or Maturity of Investments		 - 153 94 83 130 199 401
Net Cash From Financing Activities		 76 -8.59 -68 14 22 21 25
Net Cash From Continuing Financing Activities		 76 -8.59 -68 14 22 21 25
Issuance of Common Equity		 - 0.00 0.00 1.34 2.62 3.34 4.96
Other Financing Activities, net		 0.14 1.49 32 13 19 17 20
Cash Income Taxes Paid		 3.00 2.91 8.16 9.05 10 7.71 -0.55

Quarterly Cash Flow Statements for Cellebrite DI

No quarterly cash flow statements for Cellebrite DI are available.

Annual Balance Sheets for Cellebrite DI

This table presents Cellebrite DI's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2023 12/31/2023 12/31/2024 12/31/2025
Total Assets		 364 340 533 533 691 939
Total Current Assets		 324 273 422 422 568 576
Cash & Equivalents		 129 146 190 190 192 124
Short-Term Investments		 - 0.00 39 39 102 152
Accounts Receivable		 66 68 77 77 82 105
Inventories, net		 4.75 6.51 9.94 9.94 8.94 7.60
Prepaid Expenses		 7.44 13 26 26 23 20
Other Current Assets		 112 40 80 80 160 168
Plant, Property, & Equipment, net		 16 17 16 16 17 22
Total Noncurrent Assets		 24 50 95 95 106 341
Long-Term Investments		 - 0.00 29 29 37 98
Goodwill		 9.46 27 27 27 29 120
Intangible Assets		 6.61 11 11 11 11 81
Noncurrent Deferred & Refundable Income Taxes		 7.37 9.80 7.02 7.02 11 11
Other Noncurrent Operating Assets		 0.57 1.96 22 22 18 31
Total Liabilities & Shareholders' Equity		 364 340 533 533 691 939
Total Liabilities		 199 413 499 499 355 455
Total Current Liabilities		 159 187 254 254 296 370
Accounts Payable		 54 64 53 53 74 88
Current Deferred Revenue		 106 123 196 196 217 278
Other Current Liabilities		 - 0.00 4.97 4.97 4.13 4.00
Total Noncurrent Liabilities		 40 227 245 245 59 85
Noncurrent Deferred Revenue		 33 36 47 47 45 50
Other Noncurrent Operating Liabilities		 6.19 190 198 198 14 35
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 64 -73 34 34 336 484
Total Preferred & Common Equity		 64 -73 34 34 336 484
Total Common Equity		 64 -73 34 34 336 484
Common Stock		 34 -153 -85 -85 499 569
Retained Earnings		 28 78 118 118 -165 -87
Treasury Stock		 -0.09 -0.09 -0.09 -0.09 -0.09 -0.09
Accumulated Other Comprehensive Income / (Loss)		 1.32 1.37 1.05 1.05 2.09 2.22

Quarterly Balance Sheets for Cellebrite DI

No quarterly balance sheets for Cellebrite DI are available.

Annual Metrics And Ratios for Cellebrite DI

This table displays calculated financial ratios and metrics derived from Cellebrite DI's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - 239,470,062.00
DEI Adjusted Shares Outstanding		 - - - - - - 239,470,062.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - 0.32
Growth Metrics		 - - - - - - -
Profitability Metrics		 - - - - - - -
Net Operating Profit after Tax (NOPAT)		 2.02 4.68 12 1.04 23 40 57
Return On Investment Capital (ROIC_SIMPLE)		 - - - 1.41% 68.01% 11.85% 11.86%
Earnings before Interest and Taxes (EBIT)		 1.42 11 82 121 -76 -276 91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 5.49 17 89 130 -67 -268 100
Valuation Ratios		 - - - - - - -
Leverage & Solvency		 - - - - - - -
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -26 262 -138 166 -189 -47
Efficiency Ratios		 - - - - - - -
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.00 31 -219 -81 -223 5.94 110
Increase / (Decrease) in Invested Capital		 0.00 31 -250 139 -142 229 104
Book Value per Share		 $0.00 $0.52 ($0.51) $0.39 $0.18 $1.60 $2.02
Tangible Book Value per Share		 $0.00 $0.39 ($0.77) $0.19 ($0.02) $1.41 $1.18
Total Capital		 0.00 165 -73 74 34 336 484
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 -134 -146 -154 -257 -330 -374
Capital Expenditures (CapEx)		 6.21 6.18 5.11 6.90 5.23 8.57 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 31 -59 -44 -60 -21 -70
Debt-free Net Working Capital (DFNWC)		 0.00 165 87 88 168 272 206
Net Working Capital (NWC)		 0.00 165 87 88 168 272 206
Net Nonoperating Expense (NNE)		 3.89 -1.11 -59 -120 104 323 -21
Net Nonoperating Obligations (NNO)		 0.00 -134 -146 -154 -257 -330 -374
Total Depreciation and Amortization (D&A)		 4.08 5.88 7.01 8.82 8.91 7.70 9.50
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.49 $0.00 $0.00 ($1.35) $0.32
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 144.00M 0.00 0.00 209.47M 241.63M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.44 $0.00 $0.00 ($1.35) $0.31
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 161.54M 0.00 0.00 209.47M 249.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 188.54M 0.00 0.00 239.47M 249.44M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.06 4.68 12 0.73 23 40 57
Debt Service Ratios		 - - - - - - -
Payout Ratios		 - - - - - - -

Quarterly Metrics And Ratios for Cellebrite DI

No quarterly metrics and ratios for Cellebrite DI are available.


Financials Breakdown Chart

Cellebrite DI Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cellebrite DI's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Cellebrite DI's net income appears to be on an upward trend, with a most recent value of $78.33 million in 2025, falling from -$1.88 million in 2019. The previous period was -$283.01 million in 2024. See where experts think Cellebrite DI is headed by visiting Cellebrite DI's forecast page.

Cellebrite DI's total operating income in 2025 was $66.48 million, based on the following breakdown:
  • Total Gross Profit: $400.50 million
  • Total Operating Expenses: $334.02 million

Over the last 6 years, Cellebrite DI's total revenue changed from $171.85 million in 2019 to $475.68 million in 2025, a change of 176.8%.

Cellebrite DI's total liabilities were at $454.53 million at the end of 2025, a 28.2% increase from 2024, and a 128.0% increase since 2020.

In the past 5 years, Cellebrite DI's cash and equivalents has ranged from $124.46 million in 2025 to $191.66 million in 2024, and is currently $124.46 million as of their latest financial filing in 2025.

Over the last 6 years, Cellebrite DI's book value per share changed from 0.00 in 2019 to 2.02 in 2025, a change of 202.3%.


Related Companies

Financial statements for NASDAQ:CLBT last updated on 3/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
The digital asset institutions are buying before headlines hit
JPMorgan is processing $2 billion a day through new digital rails. BlackRock's tokenized fund crossed $2.8 bil...
Awesomely, LLC | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Elon Confirms SpaceX IPO For 6/12 [Act Now!]
Elon Musk has confirmed SpaceX will IPO on Friday, June 12, 2026, at a valuation of up to $2 trillion - potent...
Paradigm Press | Sponsoredtc pixel